277 related articles for article (PubMed ID: 37762479)
1. Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.
Olloquequi J; Ettcheto M; Cano A; Fortuna A; Bicker J; Sánchez-Lopez E; Paz C; Ureña J; Verdaguer E; Auladell C; Camins A
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762479
[TBL] [Abstract][Full Text] [Related]
2. Licochalcone B attenuates neuronal injury through anti-oxidant effect and enhancement of Nrf2 pathway in MCAO rat model of stroke.
Zhou B; Wang H; Zhang B; Zhang L
Int Immunopharmacol; 2021 Nov; 100():108073. PubMed ID: 34454290
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 signaling and autophagy are complementary in protecting lipopolysaccharide/d-galactosamine-induced acute liver injury by licochalcone A.
Lv H; Yang H; Wang Z; Feng H; Deng X; Cheng G; Ci X
Cell Death Dis; 2019 Apr; 10(4):313. PubMed ID: 30952839
[TBL] [Abstract][Full Text] [Related]
4. Licochalcone E activates Nrf2/antioxidant response element signaling pathway in both neuronal and microglial cells: therapeutic relevance to neurodegenerative disease.
Kim SS; Lim J; Bang Y; Gal J; Lee SU; Cho YC; Yoon G; Kang BY; Cheon SH; Choi HJ
J Nutr Biochem; 2012 Oct; 23(10):1314-23. PubMed ID: 22227268
[TBL] [Abstract][Full Text] [Related]
5. NF-κB and Nrf2 pathways contribute to the protective effect of Licochalcone A on dextran sulphate sodium-induced ulcerative colitis in mice.
Liu D; Huo X; Gao L; Zhang J; Ni H; Cao L
Biomed Pharmacother; 2018 Jun; 102():922-929. PubMed ID: 29710547
[TBL] [Abstract][Full Text] [Related]
6. Licochalcone E, a β-Amyloid Aggregation Inhibitor, Regulates Microglial M1/M2 Polarization via Inhibition of CTL1-Mediated Choline Uptake.
Muto E; Okada T; Yamanaka T; Uchino H; Inazu M
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830561
[TBL] [Abstract][Full Text] [Related]
7. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
[TBL] [Abstract][Full Text] [Related]
8. Anti-Inflammatory Effects of Licochalcone A on IL-1β-Stimulated Human Osteoarthritis Chondrocytes.
Jia T; Qiao J; Guan D; Chen T
Inflammation; 2017 Dec; 40(6):1894-1902. PubMed ID: 28756519
[TBL] [Abstract][Full Text] [Related]
9. Activating Nrf2 signalling alleviates osteoarthritis development by inhibiting inflammasome activation.
Yan Z; Qi W; Zhan J; Lin Z; Lin J; Xue X; Pan X; Zhou Y
J Cell Mol Med; 2020 Nov; 24(22):13046-13057. PubMed ID: 32965793
[TBL] [Abstract][Full Text] [Related]
10. Licochalcone-A induces intrinsic and extrinsic apoptosis via ERK1/2 and p38 phosphorylation-mediated TRAIL expression in head and neck squamous carcinoma FaDu cells.
Park MR; Kim SG; Cho IA; Oh D; Kang KR; Lee SY; Moon SM; Cho SS; Yoon G; Kim CS; Oh JS; You JS; Kim DK; Seo YS; Im HJ; Kim JS
Food Chem Toxicol; 2015 Mar; 77():34-43. PubMed ID: 25572524
[TBL] [Abstract][Full Text] [Related]
11. Lico A Enhances Nrf2-Mediated Defense Mechanisms against t-BHP-Induced Oxidative Stress and Cell Death via Akt and ERK Activation in RAW 264.7 Cells.
Lv H; Ren H; Wang L; Chen W; Ci X
Oxid Med Cell Longev; 2015; 2015():709845. PubMed ID: 26576227
[TBL] [Abstract][Full Text] [Related]
12. Janus kinase 2 inhibition by Licochalcone B suppresses esophageal squamous cell carcinoma growth.
Song M; Yoon G; Choi JS; Kim E; Liu X; Oh HN; Chae JI; Lee MH; Shim JH
Phytother Res; 2020 Aug; 34(8):2032-2043. PubMed ID: 32144852
[TBL] [Abstract][Full Text] [Related]
13. Licochalcone A: An effective and low-toxicity compound against Toxoplasma gondii in vitro and in vivo.
Si H; Xu C; Zhang J; Zhang X; Li B; Zhou X; Zhang J
Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):238-245. PubMed ID: 29684680
[TBL] [Abstract][Full Text] [Related]
14. Licochalcone B, a chalcone derivative from Glycyrrhiza inflata, as a multifunctional agent for the treatment of Alzheimer's disease.
Cao Y; Xu W; Huang Y; Zeng X
Nat Prod Res; 2020 Mar; 34(5):736-739. PubMed ID: 30345819
[TBL] [Abstract][Full Text] [Related]
15. Licochalcone A Attenuates Lipopolysaccharide-Induced Acute Kidney Injury by Inhibiting NF-κB Activation.
Hu J; Liu J
Inflammation; 2016 Apr; 39(2):569-74. PubMed ID: 26552405
[TBL] [Abstract][Full Text] [Related]
16. Licochalcone A promotes renewal of intestinal mucosa through modulating uc.173.
Wang Y; Li Y; Song C; Ke J; Zheng Y; Chen G; Li N
J Ethnopharmacol; 2024 Jan; 318(Pt B):117044. PubMed ID: 37586439
[TBL] [Abstract][Full Text] [Related]
17. Licochalcone A Upregulates Nrf2 Antioxidant Pathway and Thereby Alleviates Acetaminophen-Induced Hepatotoxicity.
Lv H; Xiao Q; Zhou J; Feng H; Liu G; Ci X
Front Pharmacol; 2018; 9():147. PubMed ID: 29628888
[TBL] [Abstract][Full Text] [Related]
18. Licochalcones suppress degranulation by decreasing the intracellular Ca2+ level and tyrosine phosphorylation of ERK in RBL-2H3 cells.
Tanifuji S; Aizu-Yokota E; Funakoshi-Tago M; Sonoda Y; Inoue H; Kasahara T
Int Immunopharmacol; 2010 Jul; 10(7):769-76. PubMed ID: 20399908
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone F alleviates glucose tolerance and chronic inflammation in diet-induced obese mice through Akt and p38 MAPK.
Bak EJ; Choi KC; Jang S; Woo GH; Yoon HG; Na Y; Yoo YJ; Lee Y; Jeong Y; Cha JH
Clin Nutr; 2016 Apr; 35(2):414-421. PubMed ID: 25823386
[TBL] [Abstract][Full Text] [Related]
20. Licochalcone B induces apoptosis of human oral squamous cell carcinoma through the extrinsic- and intrinsic-signaling pathways.
Oh H; Yoon G; Shin JC; Park SM; Cho SS; Cho JH; Lee MH; Liu K; Cho YS; Chae JI; Shim JH
Int J Oncol; 2016 Apr; 48(4):1749-57. PubMed ID: 26847145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
